drugset / Trial / NCT06099873

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

NCT06099873

Phase 3 Completed 361 enrolled Nanjing Zenshine Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary object of this study is evaluating the efficacy of ZX-7101A tablets versus placebo in the treatment of uncomplicated simple influenza in adolescents. The seongdary object is evaluating the safety of ZX-7101A tablet in the treatment of uncomplicated simple influenza in adolescents.

Timeline

Start
2023-11-30
Primary completion
2025-02-13
Completion
2025-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject ZX-7101A Unknown 40 mg Oral